14 related articles for article (PubMed ID: 2167410)
1. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
[TBL] [Abstract][Full Text] [Related]
2. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
3. KU 812: a pluripotent human cell line with spontaneous erythroid terminal maturation.
Nakazawa M; Mitjavila MT; Debili N; Casadevall N; Mayeux P; Rouyer-Fessard P; Dubart A; Roméo PH; Beuzard Y; Kishi K
Blood; 1989 May; 73(7):2003-13. PubMed ID: 2540861
[TBL] [Abstract][Full Text] [Related]
4. HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation.
Cheng T; Erickson-Miller CL; Li C; Cardier J; Wang Y; Dempsey J; Mogle M; Barbera E; Murphy MJ; Dai W
Leukemia; 1995 Jul; 9(7):1257-63. PubMed ID: 7543177
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
6. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
Hirata J; Sato H; Takahira H; Shiokawa S; Endo T; Nishimura J; Katsuno M; Masuda S; Sasaki R; Fukumaki Y
Leukemia; 1990 May; 4(5):365-72. PubMed ID: 2167410
[TBL] [Abstract][Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
